Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Bassil, Reina, Shields, Kenneth, Granger, Kevin, Zein, Ivan, Ng, Shirley, Chih, Ben
Published in Nature communications (01.09.2021)
Published in Nature communications (01.09.2021)
Get full text
Journal Article
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Boni, Valentina, Fidler, Mary J, Arkenau, Hendrik-Tobias, Spira, Alexander, Meric-Bernstam, Funda, Uboha, Nataliya, Sanborn, Rachel E, Sweis, Randy F, LoRusso, Patricia, Nagasaka, Misako, Garcia-Corbacho, Javier, Jalal, Shadia, Harding, James J, Kim, Stella K, Miedema, Iris H C, Vugts, Danielle J, Huisman, Marc C, Zwezerijnen, Gerben J C, van Dongen, Guus A M S, Menke van der Houven van Oordt, C Willemien, Wang, Song, Dang, Tam, Zein, Ivan A, Vasiljeva, Olga, Lyman, Susan K, Paton, Virginia, Hannah, Alison, Liu, Joyce F
Published in Clinical cancer research (13.05.2022)
Published in Clinical cancer research (13.05.2022)
Get full text
Journal Article
Evidence of intratumoral localization, activation, and immunomodulatory effect of CX-072, a probody therapeutic targeting PD-L1, in a phase I/II trial
Lyman, Susan, Naing, Aung, Zein, Ivan Adiputra, Howng, Bruce, Winter, Michael B., Vasiljeva, Olga, Garner, William, Zheng, Beiyao, Stroh, Mark, Kavanaugh, W Michael, Desnoyers, Luc Roland
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract PS11-07: Intratumoral activation and phase 1/2 clinical activity of CX-2009, a probody drug conjugate (PDC) targeting CD166
Liu, Joyce F., Zein, Ivan A., Dang, Tam, Lyman, Susan K., Spira, Alexander, Uboha, Nataliya, LoRusso, Patricia, Fidler, Mary J., Meric-Bernstam, Funda, Arkenau, Tobias, Nagasaka, Misako, Desnoyers, Luc R., Kavanaugh, William M., Paton, Virginia, Hannah, Alison, Boni, Valentina
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article